Literature DB >> 6454756

Haplotype-specific suppression of antibody responses in vitro. I. Generation of genetically restricted suppressor T cells by neonatal treatment with semiallogeneic spleen cells.

C M Sorensen, C W Pierce.   

Abstract

C57BL/10 mice were injected with semiallogeneic (B10.D2 X C57BL/10)F(1) spleen cells via the anterior facial vein within 24 h of birth to induce tolerance to B10.D2 (H-2(d)) alloantigens. Spleen cells from these mice as adults developed reduced, but significant, mixed lymphocyte and cytotoxic lymphocyte responses in vitro to H-2(d) stimulator cells and these treated mice rejected first-set B10.D2 skin grafts within a normal time-course, indicating that at best only a state of partial tolerance had been induced. Spleen cells from these mice failed to develop antibody responses to a variety of antigens in vitro when H-2(d) macrophages were in the cultures. Partially purified T cells from these neonatally treated mice suppressed primary antibody responses by normal syngeneic spleen cells in the presence of H-2(d) but not other allogeneic macrophages. These radiosensitive, haplotype-specific suppressor T (Ts) cells inhibited primary antibody responses by blocking initiation of the response, but failed to suppress secondary antibody responses and mixed lymphocyte or cytotoxic lymphocyte responses by appropriate responding spleen cells. To activate H-2(d) haplotype-specific Ts cells, stimulation with IA(d) subregion antigen(s) was necessary and sufficient; syngenicity at the I-A subregion of H-2 between the activated Ts cells and target responding spleen cell populations was also necessary and sufficient to achieve suppression. Comparable results have been obtained with spleen cells from BALB/c mice injected as neonates with (B10.D2 x C57BL/10)F(1) spleen cells where IA(b) antigens activate the haplotype-specific Ts cells. Implications for the significance of this population of haplotype-specific Ts cells in immune regulation are discussed and the properties of these Ts cells are compared and contrasted with other antigen-specific and nonspecific Ts cells whose activity is restricted by I- region products.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454756      PMCID: PMC2186404          DOI: 10.1084/jem.154.1.35

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  The suppressive effect of carrier priming on the response to a hapten-carrier conjugate.

Authors:  C J Elson; R B Taylor
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

4.  Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.

Authors:  J A Kapp; C W Pierce; B Benacerraf
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

5.  The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.

Authors:  S K Pierce; N R Klinman
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

6.  Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex.

Authors:  D H Katz; M Graves; M E Dorf; H Dimuzio; B Benacerraf
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

7.  Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes.

Authors:  S S Rich; R R Rich
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

8.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

9.  The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens.

Authors:  P Erb; M Feldmann
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.

Authors:  J A Kapp; C W Pierce; B Benacerraf
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  9 in total

1.  Isolation of a bovine serum albumin-specific T-suppressor cell clone and evaluation of its in vitro functions.

Authors:  J Degwert; R Bettmann; J Heuer; E Kölsch
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

2.  Selection of BW 5147 subclones devoid of non-specific suppressive activity for use in cell hybridization.

Authors:  G Chaouat; M Liacopoulos-Briot; J Couderc; J Parlebas; Y Perrodon; O Briffaut; P Liacopoulos
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

3.  Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells.

Authors:  S Rich
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

4.  Antigen-specific, I-A-restricted suppressor hybridomas with spontaneous cytolytic activity. Functional properties and lack of rearrangement of the T cell receptor beta chain genes.

Authors:  C A Blanckmeister; K Yamamoto; M M Davis; G J Hämmerling
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

5.  Haplotype-specific suppression of antibody responses in vitro. II. Suppressor factor produced by T cells and T cell hybridomas from mice treated as neonates with semiallogeneic spleen cells.

Authors:  C M Sorensen; C W Pierce
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

6.  Genetic control of the immune response to myoglobins. Both low and high responder T cells tolerant to the other major histocompatibility complex help high but not low responder B cells.

Authors:  Y Kohno; J A Berzofsky
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

7.  T cell regulation of B cell activation. I-A-restricted T suppressor cells inhibit the major histocompatibility complex-restricted interactions of T helper cells with B cells and accessory cells.

Authors:  Y Asano; R J Hodes
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

8.  T cell regulation of B cell activation. Lyt-1+,2-T cells modify the MHC-restricted function of heterogeneous and cloned T suppressor cells.

Authors:  Y Asano; R J Hodes
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

9.  Antigen-specific suppression in genetic responder mice to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). Characterization of conventional and hybridoma-derived factors produced by suppressor T cells from mice injected as neonates with syngeneic GAT macrophages.

Authors:  C M Sorensen; C W Pierce
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.